Xiangpeng Dai Selected Research

Drug Therapy (Chemotherapy)

1/2022

Combination of the 6-thioguanine and disulfiram/Cu synergistically inhibits proliferation of triple-negative breast cancer cells by enhancing DNA damage and disrupting DNA damage checkpoint.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiangpeng Dai Research Topics

Disease

31	Neoplasms (Cancer) 06/2023 - 05/2014
13	Carcinogenesis 01/2022 - 04/2014
8	Prostatic Neoplasms (Prostate Cancer) 01/2024 - 09/2015
6	Melanoma (Melanoma, Malignant) 01/2022 - 08/2013
3	Breast Neoplasms (Breast Cancer) 06/2023 - 01/2020
3	Triple Negative Breast Neoplasms 01/2023 - 01/2020
3	Neoplasm Metastasis (Metastasis) 01/2022 - 07/2017
2	Body Weight (Weight, Body) 04/2024 - 11/2022
2	Hematologic Neoplasms (Hematological Malignancy) 03/2024 - 06/2023
2	Neuroblastoma 01/2023 - 01/2022
2	Leukemia 01/2020 - 09/2017
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 04/2024
1	Stomach Neoplasms (Stomach Cancer) 01/2024
1	Lung Neoplasms (Lung Cancer) 01/2023
1	Autoimmune Diseases (Autoimmune Disease) 01/2023
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2023
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2023
1	Inflammation (Inflammations) 11/2022
1	Immune System Diseases (Immune Disorders) 01/2022
1	Food Hypersensitivity (Food Allergy) 01/2022
1	Dermatitis 01/2022
1	Deficiency Diseases (Deficiency Disease) 01/2022
1	Virus Diseases (Viral Diseases) 01/2022
1	Nevus (Nevi) 12/2018
1	Alzheimer Disease (Alzheimer's Disease) 10/2018
1	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2018
1	Starvation 01/2018
1	Pathologic Processes 01/2018
1	Carcinoma (Carcinomatosis) 05/2016
1	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 05/2014

Drug/Important Bio-Agent (IBA)

16	Proteins (Proteins, Gene)FDA Link 01/2024 - 05/2016
6	Oncogene Proteins (Oncogene Protein)IBA 01/2018 - 05/2014
5	Cullin Proteins (Cullins)IBA 01/2023 - 01/2017
5	Ligases (Synthetase)IBA 01/2023 - 04/2014
5	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2021 - 09/2015
4	Phosphotransferases (Kinase)IBA 01/2021 - 12/2015
3	Chimeric Antigen ReceptorsIBA 03/2024 - 01/2021
3	UbiquitinIBA 01/2023 - 04/2014
3	Immune Checkpoint InhibitorsIBA 01/2023 - 01/2018
2	Blood Glucose (Blood Sugar)IBA 04/2024 - 11/2022
2	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2022
2	Transcription Factors (Transcription Factor)IBA 01/2023 - 01/2022
2	Disulfiram (Antabuse)FDA Link 01/2023 - 01/2022
2	Glucose (Dextrose)FDA LinkGeneric 11/2022 - 01/2021
2	Thioguanine (Tioguanine)FDA Link 01/2022 - 01/2020
2	Histones (Histone)IBA 01/2022 - 05/2016
2	CyclinsIBA 07/2019 - 01/2018
1	Streptozocin (Streptozotocin)FDA Link 04/2024
1	Eosine Yellowish-(YS) (Eosin)IBA 04/2024
1	Nicotinamide MononucleotideIBA 04/2024
1	T-Lymphoma Invasion and Metastasis-inducing Protein 1IBA 01/2024
1	disulfiram-copperIBA 01/2023
1	Therapeutic UsesIBA 01/2023
1	CopperIBA 01/2023
1	Phenobarbital (Luminal)FDA Link 01/2023
1	VaccinesIBA 01/2023
1	Protein Subunit VaccinesIBA 01/2023
1	Interleukin-10 (Interleukin 10)IBA 11/2022
1	Sirtuin 1IBA 01/2022
1	Proto-Oncogene Proteins B-rafIBA 01/2022
1	DNA (Deoxyribonucleic Acid)IBA 01/2022
1	Immunoglobulin E (IgE)IBA 01/2022
1	CRISPR-Associated Protein 9IBA 01/2021
1	Dynamins (Dynamin)IBA 12/2020
1	Deubiquitinating EnzymesIBA 12/2020
1	Peptide Hydrolases (Proteases)FDA Link 12/2020
1	6-methyladenineIBA 01/2020
1	Amyloid (Amyloid Fibrils)IBA 10/2018
1	Protein Kinases (Protein Kinase)IBA 01/2018
1	Programmed Cell Death 1 ReceptorIBA 01/2018
1	LigandsIBA 01/2018
1	B7-H1 AntigenIBA 01/2018
1	Histone Deacetylase 6IBA 07/2017
1	benzyloxycarbonylleucyl-leucyl-leucine aldehydeIBA 07/2017
1	pevonedistatIBA 07/2017
1	bafilomycin A1IBA 07/2017
1	Proteasome InhibitorsIBA 07/2017
1	Androgen Receptors (Androgen Receptor)IBA 01/2017
1	Mechanistic Target of Rapamycin Complex 2IBA 01/2017
1	Cyclin D1IBA 01/2017
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2017
1	TransferasesIBA 05/2016
1	TNF Receptor-Associated Factor 2 (TRAF2)IBA 05/2016
1	MethyltransferasesIBA 12/2015
1	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2015
1	PAX3 Transcription FactorIBA 09/2015
1	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 01/2015
1	EnzymesIBA 01/2015
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2015
1	Small Interfering RNA (siRNA)IBA 05/2014
1	Antimitotic AgentsIBA 05/2014
1	Antineoplastic Agents (Antineoplastics)IBA 05/2014
1	Anaphase-Promoting Complex-CyclosomeIBA 04/2014
1	Type 1 Melanocortin ReceptorIBA 08/2013

Therapy/Procedure

10	Therapeutics 06/2023 - 01/2017
7	Immunotherapy 03/2024 - 01/2021
1	Drug Therapy (Chemotherapy) 01/2022
1	Hematopoietic Stem Cell Transplantation 01/2022
1	Molecular Targeted Therapy 01/2022
1	Oncolytic Virotherapy 01/2021